HealthEquity rated Moderate Buy by Wall Street analysts
Alpha Vantage · MarketBeat · · AI-summarised by FinFlash
HealthEquity (NASDAQ:HQY) carries a "Moderate Buy" consensus from Wall Street analysts, with an average 12-month price target of Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.Understand the context